Integrative multi-omic analysis reveals a PAX8-driven gene network linking tumor stemness to therapy response in ovarian cancer
NAR Genomics and Bioinformatics · 2025
DOI: 10.1093/nargab/lqaf113 ↗Kurz gefasst
Fachartikel in der Zeitschrift NAR Genomics and Bioinformatics, 2025. Verfasst von José M Santos-Pereira und 2 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla/Consejo Superior de Investigaciones Cientí…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, PAX8 Transcription Factor, Gene Regulatory Networks, Neoplastic Stem Cells. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundación Ramón Areces, Consejería de Salud y Consumo, Junta de Andalucía, AEI.
Abstract (Originalsprache)
The transcription factor PAX8 is expressed in most ovarian tumors, being associated with increased tumorigenesis. Although recent studies have addressed the gene regulatory functions of PAX8 in ovarian cancer, an integrative analysis of multi-omic and patient data is required to identify the core regulatory network of PAX8 and its prognostic and therapeutic value. Here, we integrate PAX8 chromatin binding and accessibility data in ovarian cancer cells with transcriptomic and patients’ data to gain insight into the core gene regulatory network orchestrated by PAX8 in ovarian tumors. Integration of differential chromatin accessibility, transcription factor binding, and gene expression upon PAX8 knockout provides a core regulatory network that explains most of the genes regulated by PAX8. We combine these target genes with patient expression data and find a PAX8 gene signature associated with tumor stemness, a property related to therapy resistance. Indeed, we show that the PAX8 gene signature predicts disease outcome and response to therapy in ovarian cancer patients. Finally, we validated experimentally our results from bioinformatic analyses, thus reassuring their robustness. Our findings uncover a PAX8 core network that represents a promising strategy for targeted antitumor therapies and open new pathways to fight against ovarian cancer resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla/Consejo Superior de Investigaciones Científicas, Avda. Manuel Siurot s/n 41013, Seville, Spain.
- Departamento de Biología Celular, Facultad de Biología, Universidad de Sevilla, 41012 Sevilla, Spain.
- CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.
ORCID-Profile: José M Santos-Pereira, Amancio Carnero, Sandra Muñoz-Galván
Förderung
- Fundación Ramón Areces
- Consejería de Salud y Consumo, Junta de Andalucía
- AEI
- ERDF A way of making Europe
- CIBER de Cáncer
- Emergia
- Junta de Andalucía
- European Union
Zitieren
APA
Santos-Pereira, J. M., Carnero, A., & Muñoz-Galván, S. (2025). Integrative multi-omic analysis reveals a PAX8-driven gene network linking tumor stemness to therapy response in ovarian cancer. NAR Genomics and Bioinformatics. https://doi.org/10.1093/nargab/lqaf113
Vancouver
Santos-Pereira JM, Carnero A, Muñoz-Galván S. Integrative multi-omic analysis reveals a PAX8-driven gene network linking tumor stemness to therapy response in ovarian cancer. NAR Genomics and Bioinformatics. 2025. doi:10.1093/nargab/lqaf113
BibTeX
@article{SantosPereira2025,
author = {Santos-Pereira, José M and Carnero, Amancio and Muñoz-Galván, Sandra},
title = {Integrative multi-omic analysis reveals a PAX8-driven gene network linking tumor stemness to therapy response in ovarian cancer},
journal = {NAR Genomics and Bioinformatics},
year = {2025},
doi = {10.1093/nargab/lqaf113}
}
EUVIMED